Nicardipine enhances diaphragmatic fatigue

Area of Science:

• Respiratory Physiology
• Pharmacology
• Critical Care Medicine

Background:

• Diaphragmatic fatigue is a significant concern in mechanically ventilated patients.
• Calcium channel blockers are used in critical care, but their effects on respiratory muscles are not fully understood.
• Nicardipine is a dihydropyridine calcium channel blocker.

Purpose of the Study:

• To investigate the effects of nicardipine on the development of diaphragmatic fatigue.
• To assess the impact of nicardipine on diaphragmatic contractility and electrical activity during induced fatigue.

Main Methods:

• Twenty anesthetized, mechanically ventilated dogs were divided into control and nicardipine groups.
• Diaphragmatic fatigue was induced via intermittent phrenic nerve stimulation.
• Transdiaphragmatic pressure (Pdi) and integrated diaphragmatic electrical activity (Edi) were measured as indices of contractility and activity.

Main Results:

• Diaphragmatic fatigue, indicated by decreased Pdi at low-frequency stimulation, occurred in both groups.
• The reduction in Pdi at low frequencies was significantly greater in the nicardipine group compared to the control group.
• Nicardipine administration did not alter diaphragmatic electrical activity (Edi) at any stimulation frequency.

Conclusions:

• Nicardipine administration enhances the development of diaphragmatic fatigue in this canine model.
• The findings suggest that nicardipine may impair respiratory muscle function, potentially increasing the risk of weaning failure in critically ill patients.
• Further research is warranted to elucidate the mechanisms behind nicardipine-induced potentiation of diaphragmatic fatigue.